ClinicalTrials.Veeva

Menu

OST and MORES in Male Osteoporosis

K

Kayseri City Hospital

Status

Active, not recruiting

Conditions

Male Osteoporosis

Study type

Observational

Funder types

Other

Identifiers

NCT07518212
Male osteoporosis

Details and patient eligibility

About

The aim of this study is to compare the Male Osteoporosis Risk Score and the Osteoporosis Self-Assessment Tool with the gold standard DEXA in determining the risk of osteoporosis in the lumbar and femoral regions in male individuals in the Turkish population, and to investigate their sensitivity and specificity in the first stage of screening for the detection of male osteoporosis.

Full description

This study will be conducted as a single-center, retrospective study at the Physical Medicine and Rehabilitation Clinic of Kayseri City Hospital between January 2024 and January 2025. Male patients aged 50-75 who underwent osteoporosis screening with DEXA between January 2021 and January 2024 at the FTR outpatient clinics of Kayseri City Hospital will be included in this study. Patient data will be obtained retrospectively from the hospital database. Sociodemographic data (age, height, weight, body mass index) and current laboratory data (complete blood count, biochemical values (fasting blood sugar, BUN, creatinine, AST, ALT, calcium, phosphorus, alkaline phosphatase, total protein, albumin, parathyroid hormone, vitamin D3, T4, TSH), and DEXA values (bone mineral density, lumbar vertebrae, and total T scores for the femoral neck and femur) will be recorded. The OST score will be calculated using body weight and age parameters. The MORES score will be calculated based on age, weight, and hospital data, specifically the presence of chronic obstructive pulmonary disease (COPD) with ICD-10 code: J44 and its subgroups.

The data will be evaluated using the SPSS 24.0 software package. Descriptive statistical analyses will include calculations of mean, standard deviation, frequency, and percentages. In comparative statistics, the Student's t-test or Mann-Whitney U test will be used to compare independent groups. Chi-square analysis will be applied to compare categorical variables. Pearson or Spearman correlation analyses will be applied to evaluate the relationship between variables. Both groups will be compared, and p<0.05 will be considered statistically significant.

Enrollment

140 estimated patients

Sex

Male

Ages

50 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

İnclusion criteria:

  • Men aged 50-75
  • Patients who underwent imaging with the STRATOS DEXA device at Kayseri City Hospital

Exclusion criteria:

  • Patients younger than 50 or older than 75 years of age
  • Patients with secondary osteoporosis
  • Female patients
  • Patients with uncontrolled severe comorbid conditions
  • Patients with a history of pathological fractures

Trial design

140 participants in 1 patient group

male osteoporosis group

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems